Effect of basic fibroblast growth factor on myocardial angiogenesis in dogs with mature collateral vessels

Journal of the American College of Cardiology

Volumn 29, Issue 5, 1997, Pages 1102-1106

  Shou, Matie ^a   Thirumurti, Venugopal ^a   Rajanayagam, M A Sharmini ^a   Lazarous, Daisy F ^a   Hodge, Everett ^a   Stiber, Jonathan A ^a   Pettiford, Mary ^a   Elliott, Elizabeth ^a   Shah, Sanjay M ^a   Unger, Ellis F ^a  

^a Physiology and Pharmacology Section   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; DOG; FEMALE; HEART PERFUSION; ISCHEMIC HEART DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; COLLATERAL CIRCULATION; CORONARY VESSELS; DOGS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEMODYNAMIC PROCESSES; MALE; MICROSPHERES; NEOVASCULARIZATION, PHYSIOLOGIC; TIME FACTORS;

EID: 0030981788     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00014-4     Document Type: Article

References (15)

1. Folkman J, Klagsburn M. Angiogenic factors. Science. 235:1987;442-447.
2. Unger EF, Banai S, Shou M, et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol. 266:1994;H1588-95.
3. Lazarous DF, Scheinowitz M, Shou M, et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 91:1995;145-153.
4. Lazarous DF, Shou M, Scheinowitz M, et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation. 94:1996;1074-1082.
5. Rajanayagam S, Shou M, Thirumurti V, et al. Two intracoronary doses of basic fibroblast growth factor enhance collateral blood flow in dogs [abstract]. J Am Coll Cardiol. 27:(Suppl A):1996;36A.
6. Baer RW, Payne BD, Verrier ED, et al. Increased number of myocardial blood flow measurements with radionuclide-labeled microspheres. Am J Physiol. 246:1984;H418-34.
7. Heymann MA, Payne BD, Hoffman JIE, Rudolph AM. Blood flow measurements with radionuclide-labelled particles. Prog Cardiovasc Dis. 20:1977;55-79.
8. Schaper W, Ito WD. Molecular mechanisms of coronary collateral growth. Circ Res. 79:1996;911-919.
9. Harada K, Grossman W, Friedman M, et al. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest. 94:1994;623-630.
10. Giordano FJ, Ping P, McKirnan MD, et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med. 2:1996;534-539.
11. Auerbach R, Kabail L, Knighton D, Folkman J. A simple procedure for the long-term cultivation of chicken embryo. Dev Biol. 41:1974;391-394.
12. Fujita M, Sasayama S, Asanoi H, Nakajima H, Sakai O, Ohno A. Improvement of treadmill capacity and collateral circulation as a result of exercise with heparin pretreatment in patients with effort angina. Circulation. 77:1988;1022-1029.
13. Quyyumi AA, Diodati JG, Lakatos E, Bonow RO, Epstein SE. Angiogenic effects of low molecular weight heparin in patients with stable coronary artery disease a pilot study . J Am Coll Cardiol. 22:1993;635-641.
14. Unger EF, Banai S, Shou M, et al. A model to assess interventions to improve collateral blood flow continuous administration of agents into the left coronary artery in dogs . Cardiovasc Res. 27:1993;785-791.
15. Yang HT, Ogilvie RW, Terjung RL. Heparin increases exercise-induced collateral blood flow in rats with femoral artery ligation. Circ Res. 76:1995;448-456.